Abstracts

The Impact of Patient Support Program Participation on Treatment Compliance for Patients Initiating Ibrutinib

Introduction:Oral oncolytics offer advantages over chemotherapy, but oncology patients may face treatment compliance challenges. Previous studies have shown patient support programs (PSPs...

Karve Sudeep ;

Crawford Samuel ;

Cheng Ning ;

Chen Naijun ;

Srivastava Bhanini ;

Nielsen Jacqueline ;

11/04/2022

Updated Progression-free Survival (PFS) and Depth of Response in IKEMA, A Randomized Phase 3 Trial of Isatuximab, Carfilzomib and Dexamethasone (Isa-Kd) vs Kd in Relapsed Multiple Myeloma (MM)

Introduction:The anti-CD38 antibody Isa in combination with Kd is approved in various countries for patients (pts) with relapsed MM after ‚â•1 prior therapy, based on primary interim anal...

Thomas G. Martin III, MD;

Joseph Mikhael , MD, MEd, FRCPC;

Roman Hajek ;

Sandrine Mace ;

Phillippe Moreau ;

Kwee Yong ;

Marcelo Capra ;

Thierry Facon ;

France Casca ;

Marie-Laure Risse ;

Meletios-Athanasios Dimopoulos ;

11/04/2022

Successful Management of a Jehovah‚Äôs Witness Patient with Philadelphia Positive Acute Lymphoblastic Leukemia with Mini-HyperCVD, Ponatinib, Blinatumomab, and POMP Maintenance

Introduction:Leukemia patients who are Jehovah‚Äôs witnesses can be challenging to treat from a hematologic malignancy standpoint, as they are not permitted to accept blood or blood produ...

Kayla E. Davies ;

Joanne L. Heck ;

Richelle B. Miller ;

Reeshma Mohammad ;

Nicole Schartz ;

Rachael Yasuda , MD;

Rajneesh Nath , MD;

Nicolas de Padova ;

Jennifer Brookes ;

11/04/2022

Subcutaneous (SC) Isatuximab Administration by an On-Body Delivery System (OBDS) in Combination with Pomalidomide-Dexamethasone (Pd) in Relapsed/Refractory Multiple Myeloma (RRMM) Patients: Interim Phase 1b Study Results

Introduction:SC Isa delivery would optimize convenience of administration. Prior results showed SC Isa administered by syringe pump has efficacy and safety comparable to IV Isa; recommend...

Hang Quach ;

Gurdeep Parmar ;

Nobuhiro Tsukada ;

Kazatuka Sunami ;

Albert Oriol ;

Pierre Bories ;

Enrique M. Ocio ;

Chatchada Karanes ;

Sumit Madan ;

Dorothee Semiond ;

Marlene Inchauspe ;

Sandrine Mace ;

Florence Suzan ;

Phillippe Moreau ;

M.H. Prince ;

11/04/2022

Evaluating the Safety and Efficacy of the BeEAM (Bendamustine, Etoposide, Cytarabine & Melphalan) Conditioning Regimen for Autologous Stem Cell Transplant in Patients with Relapsed Lymphomas; A Retrospective Chart Review

Introduction:

Laura McDonald ;

Rayan Kaedbey ;

11/04/2022

VERIFY: A Phase 3 Study of the Hepcidin Mimetic Rusfertide (PTG-300) in Patients with Polycythemia Vera

Introduction:Patients with polycythemia vera (PV) are treated with periodic therapeutic phlebotomy (TP) alone or in combination with cytoreductive therapies (CRT) to maintain hematocrit (...

Srdan Verstovsek ;

Andrew Kuykendall ;

Ronald Hoffman ;

Steffen Koschmieder ;

Francesco Passamonti ;

Frank Valone ;

Nishit B. Modi ;

Sarita Khanna ;

Paula G. O'Connor ;

Suneel K. Gupta ;

Jean-Jacques Kiladjian ;

11/04/2022

Rate of Atrial Fibrillation in Patients With B-Cell Malignancies Who Undergo Treatment With Zanubrutinib

Introduction:

Constantine S. Tam ;

Jun Jie Zhang , MD;

Nicola Wallis ;

Meng Zhang ;

Soraya Azmi ;

Aileen Cohen ;

Philip T. Sager ;

11/04/2022

The Tree That Hides the Forest: An Unfortunate Story of T/NK Lymphoma

Introduction: NK/T lymphoma is a rare type of non-Hodgkin's lymphoma [1,2]. It is a clinical entity that manifests itself essentially by a necrosis that usually starts in the nasal caviti...

Naima Motassim ;

Safae E. Fari ;

Hicham Harmouche ;

Mouna Maamar ;

Zouda Tazi ;

Ammouri Wafae ;

Hajar Khibri ;

11/04/2022

Variant Acute Promyelocytic Leukemia - A Case Report of a Rare Malignancy

Introduction:Acute promyelocytic leukemia (APL) is rare and accounts for only 5-8% of acute myeloid leukemia and is characterized by t(15;17).Variant APL caused by a variant translocation...

Rathnam Krishnakumar ;

S.V. Saju ;

Susan R. Honey ;

11/04/2022

PTEN-Mutated Histiocytic Sarcoma Treated with Frontline Sirolimus and Prednisone

Introduction:Histiocytic sarcoma (HS) is an extremely rare non-Langerhans histiocytic neoplasm that can present as unifocal or multifocal disease. Multifocal disease carries an exceeding...

Oliver W. Tobin ;

Mathew Koster ;

Mithun V. Shah ;

Jay H. Ryu ;

Robert Vassallo ;

Karen L. Rech ;

Aishwarya Ravindran ;

Gaurav Goyal ;

Ronald S. Go ;

Nora N. Bennani ;

Karan Chohan ;

Jason R. Young ;